 | • レポートコード：QFJ1-4027 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、臨床腫瘍学次世代シーケンシングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（全ゲノムシーケンシング、全エクソームシーケンシング、ターゲットシーケンシングおよびリシーケンシング遠心分離機）、用途別市場規模（病院、診療所、研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・臨床腫瘍学次世代シーケンシングの市場動向 ・企業の競争状況、市場シェア ・臨床腫瘍学次世代シーケンシングの種類別市場規模と予測2016-2027（全ゲノムシーケンシング、全エクソームシーケンシング、ターゲットシーケンシングおよびリシーケンシング遠心分離機） ・臨床腫瘍学次世代シーケンシングの用途別市場規模と予測2016-2027（病院、診療所、研究所） ・臨床腫瘍学次世代シーケンシングの北米市場規模2016-2027（アメリカ、カナダ） ・臨床腫瘍学次世代シーケンシングの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・臨床腫瘍学次世代シーケンシングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・臨床腫瘍学次世代シーケンシングの中南米市場規模2016-2027（メキシコ、ブラジル） ・臨床腫瘍学次世代シーケンシングの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Illumina, Inc.、Thermo Fisher Scientific、F. Hoffmann-La Roche Ltd.、Agilent Technologies、Myriad Genetics、Beijing Genomics Institute (BGI)、Perkin Elmer、Foundation Medicine、Pacific Bioscience、Oxford Nanopore Technologies Ltd.、Paradigm Diagnostics、Caris Life Sciences、Partek, Inc.、Eurofins Scientific S.E.、Qiagen N.V.） ・結論 |
Next generation sequencing (NGS) has created a noteworthy paradigm shift in the clinical diagnostic field. It refers to an aggregate collection of methods in which various sequencing reactions occur at the same time, bringing about vast amounts of sequencing data for a little division of the cost of Sanger sequencing.
Market Analysis and Insights: Global Clinical Oncology Next Generation Sequencing Market
The global Clinical Oncology Next Generation Sequencing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Oncology Next Generation Sequencing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Oncology Next Generation Sequencing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Oncology Next Generation Sequencing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Oncology Next Generation Sequencing market.
Global Clinical Oncology Next Generation Sequencing Scope and Market Size
Clinical Oncology Next Generation Sequencing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Oncology Next Generation Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing & Resequencing Centrifuges
Segment by Application
Hospitals
Clinics
Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Illumina, Inc.
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd.
Agilent Technologies
Myriad Genetics
Beijing Genomics Institute (BGI)
Perkin Elmer
Foundation Medicine
Pacific Bioscience
Oxford Nanopore Technologies Ltd.
Paradigm Diagnostics
Caris Life Sciences
Partek, Inc.
Eurofins Scientific S.E.
Qiagen N.V.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Oncology Next Generation Sequencing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Whole Genome Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Targeted Sequencing & Resequencing Centrifuges
1.3 Market by Application
1.3.1 Global Clinical Oncology Next Generation Sequencing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical Oncology Next Generation Sequencing Market Perspective (2016-2027)
2.2 Clinical Oncology Next Generation Sequencing Growth Trends by Regions
2.2.1 Clinical Oncology Next Generation Sequencing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Clinical Oncology Next Generation Sequencing Historic Market Share by Regions (2016-2021)
2.2.3 Clinical Oncology Next Generation Sequencing Forecasted Market Size by Regions (2022-2027)
2.3 Clinical Oncology Next Generation Sequencing Industry Dynamic
2.3.1 Clinical Oncology Next Generation Sequencing Market Trends
2.3.2 Clinical Oncology Next Generation Sequencing Market Drivers
2.3.3 Clinical Oncology Next Generation Sequencing Market Challenges
2.3.4 Clinical Oncology Next Generation Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Oncology Next Generation Sequencing Players by Revenue
3.1.1 Global Top Clinical Oncology Next Generation Sequencing Players by Revenue (2016-2021)
3.1.2 Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Players (2016-2021)
3.2 Global Clinical Oncology Next Generation Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Clinical Oncology Next Generation Sequencing Revenue
3.4 Global Clinical Oncology Next Generation Sequencing Market Concentration Ratio
3.4.1 Global Clinical Oncology Next Generation Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Oncology Next Generation Sequencing Revenue in 2020
3.5 Clinical Oncology Next Generation Sequencing Key Players Head office and Area Served
3.6 Key Players Clinical Oncology Next Generation Sequencing Product Solution and Service
3.7 Date of Enter into Clinical Oncology Next Generation Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Oncology Next Generation Sequencing Breakdown Data by Type
4.1 Global Clinical Oncology Next Generation Sequencing Historic Market Size by Type (2016-2021)
4.2 Global Clinical Oncology Next Generation Sequencing Forecasted Market Size by Type (2022-2027)
5 Clinical Oncology Next Generation Sequencing Breakdown Data by Application
5.1 Global Clinical Oncology Next Generation Sequencing Historic Market Size by Application (2016-2021)
5.2 Global Clinical Oncology Next Generation Sequencing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Clinical Oncology Next Generation Sequencing Market Size (2016-2027)
6.2 North America Clinical Oncology Next Generation Sequencing Market Size by Type
6.2.1 North America Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021)
6.2.2 North America Clinical Oncology Next Generation Sequencing Market Size by Type (2022-2027)
6.2.3 North America Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2027)
6.3 North America Clinical Oncology Next Generation Sequencing Market Size by Application
6.3.1 North America Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021)
6.3.2 North America Clinical Oncology Next Generation Sequencing Market Size by Application (2022-2027)
6.3.3 North America Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2027)
6.4 North America Clinical Oncology Next Generation Sequencing Market Size by Country
6.4.1 North America Clinical Oncology Next Generation Sequencing Market Size by Country (2016-2021)
6.4.2 North America Clinical Oncology Next Generation Sequencing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical Oncology Next Generation Sequencing Market Size (2016-2027)
7.2 Europe Clinical Oncology Next Generation Sequencing Market Size by Type
7.2.1 Europe Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021)
7.2.2 Europe Clinical Oncology Next Generation Sequencing Market Size by Type (2022-2027)
7.2.3 Europe Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2027)
7.3 Europe Clinical Oncology Next Generation Sequencing Market Size by Application
7.3.1 Europe Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021)
7.3.2 Europe Clinical Oncology Next Generation Sequencing Market Size by Application (2022-2027)
7.3.3 Europe Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2027)
7.4 Europe Clinical Oncology Next Generation Sequencing Market Size by Country
7.4.1 Europe Clinical Oncology Next Generation Sequencing Market Size by Country (2016-2021)
7.4.2 Europe Clinical Oncology Next Generation Sequencing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size (2016-2027)
8.2 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Type
8.2.1 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2027)
8.3 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Application
8.3.1 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2027)
8.4 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Region
8.4.1 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical Oncology Next Generation Sequencing Market Size (2016-2027)
9.2 Latin America Clinical Oncology Next Generation Sequencing Market Size by Type
9.2.1 Latin America Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021)
9.2.2 Latin America Clinical Oncology Next Generation Sequencing Market Size by Type (2022-2027)
9.2.3 Latin America Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2027)
9.3 Latin America Clinical Oncology Next Generation Sequencing Market Size by Application
9.3.1 Latin America Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021)
9.3.2 Latin America Clinical Oncology Next Generation Sequencing Market Size by Application (2022-2027)
9.3.3 Latin America Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2027)
9.4 Latin America Clinical Oncology Next Generation Sequencing Market Size by Country
9.4.1 Latin America Clinical Oncology Next Generation Sequencing Market Size by Country (2016-2021)
9.4.2 Latin America Clinical Oncology Next Generation Sequencing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size (2016-2027)
10.2 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Type
10.2.1 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2027)
10.3 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Application
10.3.1 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2027)
10.4 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Country
10.4.1 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Illumina, Inc.
11.1.1 Illumina, Inc. Company Details
11.1.2 Illumina, Inc. Business Overview
11.1.3 Illumina, Inc. Clinical Oncology Next Generation Sequencing Introduction
11.1.4 Illumina, Inc. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.1.5 Illumina, Inc. Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Introduction
11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Clinical Oncology Next Generation Sequencing Introduction
11.4.4 Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.4.5 Agilent Technologies Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Details
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Clinical Oncology Next Generation Sequencing Introduction
11.5.4 Myriad Genetics Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.5.5 Myriad Genetics Recent Development
11.6 Beijing Genomics Institute (BGI)
11.6.1 Beijing Genomics Institute (BGI) Company Details
11.6.2 Beijing Genomics Institute (BGI) Business Overview
11.6.3 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Introduction
11.6.4 Beijing Genomics Institute (BGI) Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.6.5 Beijing Genomics Institute (BGI) Recent Development
11.7 Perkin Elmer
11.7.1 Perkin Elmer Company Details
11.7.2 Perkin Elmer Business Overview
11.7.3 Perkin Elmer Clinical Oncology Next Generation Sequencing Introduction
11.7.4 Perkin Elmer Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.7.5 Perkin Elmer Recent Development
11.8 Foundation Medicine
11.8.1 Foundation Medicine Company Details
11.8.2 Foundation Medicine Business Overview
11.8.3 Foundation Medicine Clinical Oncology Next Generation Sequencing Introduction
11.8.4 Foundation Medicine Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.8.5 Foundation Medicine Recent Development
11.9 Pacific Bioscience
11.9.1 Pacific Bioscience Company Details
11.9.2 Pacific Bioscience Business Overview
11.9.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing Introduction
11.9.4 Pacific Bioscience Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.9.5 Pacific Bioscience Recent Development
11.10 Oxford Nanopore Technologies Ltd.
11.10.1 Oxford Nanopore Technologies Ltd. Company Details
11.10.2 Oxford Nanopore Technologies Ltd. Business Overview
11.10.3 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Introduction
11.10.4 Oxford Nanopore Technologies Ltd. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.10.5 Oxford Nanopore Technologies Ltd. Recent Development
11.11 Paradigm Diagnostics
11.11.1 Paradigm Diagnostics Company Details
11.11.2 Paradigm Diagnostics Business Overview
11.11.3 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Introduction
11.11.4 Paradigm Diagnostics Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.11.5 Paradigm Diagnostics Recent Development
11.12 Caris Life Sciences
11.12.1 Caris Life Sciences Company Details
11.12.2 Caris Life Sciences Business Overview
11.12.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing Introduction
11.12.4 Caris Life Sciences Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.12.5 Caris Life Sciences Recent Development
11.13 Partek, Inc.
11.13.1 Partek, Inc. Company Details
11.13.2 Partek, Inc. Business Overview
11.13.3 Partek, Inc. Clinical Oncology Next Generation Sequencing Introduction
11.13.4 Partek, Inc. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.13.5 Partek, Inc. Recent Development
11.14 Eurofins Scientific S.E.
11.14.1 Eurofins Scientific S.E. Company Details
11.14.2 Eurofins Scientific S.E. Business Overview
11.14.3 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Introduction
11.14.4 Eurofins Scientific S.E. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.14.5 Eurofins Scientific S.E. Recent Development
11.15 Qiagen N.V.
11.15.1 Qiagen N.V. Company Details
11.15.2 Qiagen N.V. Business Overview
11.15.3 Qiagen N.V. Clinical Oncology Next Generation Sequencing Introduction
11.15.4 Qiagen N.V. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021)
11.15.5 Qiagen N.V. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Clinical Oncology Next Generation Sequencing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Whole Genome Sequencing
Table 3. Key Players of Whole Exome Sequencing
Table 4. Key Players of Targeted Sequencing & Resequencing Centrifuges
Table 5. Global Clinical Oncology Next Generation Sequencing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Clinical Oncology Next Generation Sequencing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Clinical Oncology Next Generation Sequencing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Clinical Oncology Next Generation Sequencing Market Share by Regions (2016-2021)
Table 9. Global Clinical Oncology Next Generation Sequencing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Clinical Oncology Next Generation Sequencing Market Share by Regions (2022-2027)
Table 11. Clinical Oncology Next Generation Sequencing Market Trends
Table 12. Clinical Oncology Next Generation Sequencing Market Drivers
Table 13. Clinical Oncology Next Generation Sequencing Market Challenges
Table 14. Clinical Oncology Next Generation Sequencing Market Restraints
Table 15. Global Clinical Oncology Next Generation Sequencing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Clinical Oncology Next Generation Sequencing Market Share by Players (2016-2021)
Table 17. Global Top Clinical Oncology Next Generation Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Oncology Next Generation Sequencing as of 2020)
Table 18. Ranking of Global Top Clinical Oncology Next Generation Sequencing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Clinical Oncology Next Generation Sequencing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Clinical Oncology Next Generation Sequencing Product Solution and Service
Table 22. Date of Enter into Clinical Oncology Next Generation Sequencing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Type (2016-2021)
Table 26. Global Clinical Oncology Next Generation Sequencing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Clinical Oncology Next Generation Sequencing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Application (2016-2021)
Table 30. Global Clinical Oncology Next Generation Sequencing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Clinical Oncology Next Generation Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Clinical Oncology Next Generation Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Clinical Oncology Next Generation Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Clinical Oncology Next Generation Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Clinical Oncology Next Generation Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Clinical Oncology Next Generation Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Clinical Oncology Next Generation Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Clinical Oncology Next Generation Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Clinical Oncology Next Generation Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Clinical Oncology Next Generation Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Clinical Oncology Next Generation Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Clinical Oncology Next Generation Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Illumina, Inc. Company Details
Table 63. Illumina, Inc. Business Overview
Table 64. Illumina, Inc. Clinical Oncology Next Generation Sequencing Product
Table 65. Illumina, Inc. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 66. Illumina, Inc. Recent Development
Table 67. Thermo Fisher Scientific Company Details
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Product
Table 70. Thermo Fisher Scientific Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 71. Thermo Fisher Scientific Recent Development
Table 72. F. Hoffmann-La Roche Ltd. Company Details
Table 73. F. Hoffmann-La Roche Ltd. Business Overview
Table 74. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Product
Table 75. F. Hoffmann-La Roche Ltd. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 76. F. Hoffmann-La Roche Ltd. Recent Development
Table 77. Agilent Technologies Company Details
Table 78. Agilent Technologies Business Overview
Table 79. Agilent Technologies Clinical Oncology Next Generation Sequencing Product
Table 80. Agilent Technologies Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 81. Agilent Technologies Recent Development
Table 82. Myriad Genetics Company Details
Table 83. Myriad Genetics Business Overview
Table 84. Myriad Genetics Clinical Oncology Next Generation Sequencing Product
Table 85. Myriad Genetics Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 86. Myriad Genetics Recent Development
Table 87. Beijing Genomics Institute (BGI) Company Details
Table 88. Beijing Genomics Institute (BGI) Business Overview
Table 89. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Product
Table 90. Beijing Genomics Institute (BGI) Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 91. Beijing Genomics Institute (BGI) Recent Development
Table 92. Perkin Elmer Company Details
Table 93. Perkin Elmer Business Overview
Table 94. Perkin Elmer Clinical Oncology Next Generation Sequencing Product
Table 95. Perkin Elmer Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 96. Perkin Elmer Recent Development
Table 97. Foundation Medicine Company Details
Table 98. Foundation Medicine Business Overview
Table 99. Foundation Medicine Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 100. Foundation Medicine Recent Development
Table 101. Pacific Bioscience Company Details
Table 102. Pacific Bioscience Business Overview
Table 103. Pacific Bioscience Clinical Oncology Next Generation Sequencing Product
Table 104. Pacific Bioscience Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 105. Pacific Bioscience Recent Development
Table 106. Oxford Nanopore Technologies Ltd. Company Details
Table 107. Oxford Nanopore Technologies Ltd. Business Overview
Table 108. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Product
Table 109. Oxford Nanopore Technologies Ltd. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 110. Oxford Nanopore Technologies Ltd. Recent Development
Table 111. Paradigm Diagnostics Company Details
Table 112. Paradigm Diagnostics Business Overview
Table 113. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Product
Table 114. Paradigm Diagnostics Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 115. Paradigm Diagnostics Recent Development
Table 116. Caris Life Sciences Company Details
Table 117. Caris Life Sciences Business Overview
Table 118. Caris Life Sciences Clinical Oncology Next Generation Sequencing Product
Table 119. Caris Life Sciences Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 120. Caris Life Sciences Recent Development
Table 121. Partek, Inc. Company Details
Table 122. Partek, Inc. Business Overview
Table 123. Partek, Inc. Clinical Oncology Next Generation Sequencing Product
Table 124. Partek, Inc. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 125. Partek, Inc. Recent Development
Table 126. Eurofins Scientific S.E. Company Details
Table 127. Eurofins Scientific S.E. Business Overview
Table 128. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Product
Table 129. Eurofins Scientific S.E. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 130. Eurofins Scientific S.E. Recent Development
Table 131. Qiagen N.V. Company Details
Table 132. Qiagen N.V. Business Overview
Table 133. Qiagen N.V. Clinical Oncology Next Generation Sequencing Product
Table 134. Qiagen N.V. Revenue in Clinical Oncology Next Generation Sequencing Business (2016-2021) & (US$ Million)
Table 135. Qiagen N.V. Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Oncology Next Generation Sequencing Market Share by Type: 2020 VS 2027
Figure 2. Whole Genome Sequencing Features
Figure 3. Whole Exome Sequencing Features
Figure 4. Targeted Sequencing & Resequencing Centrifuges Features
Figure 5. Global Clinical Oncology Next Generation Sequencing Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Laboratories Case Studies
Figure 9. Clinical Oncology Next Generation Sequencing Report Years Considered
Figure 10. Global Clinical Oncology Next Generation Sequencing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Clinical Oncology Next Generation Sequencing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Clinical Oncology Next Generation Sequencing Market Share by Regions: 2020 VS 2027
Figure 13. Global Clinical Oncology Next Generation Sequencing Market Share by Regions (2022-2027)
Figure 14. Global Clinical Oncology Next Generation Sequencing Market Share by Players in 2020
Figure 15. Global Top Clinical Oncology Next Generation Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Oncology Next Generation Sequencing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Clinical Oncology Next Generation Sequencing Revenue in 2020
Figure 17. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Type (2016-2021)
Figure 18. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Type (2022-2027)
Figure 19. North America Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Clinical Oncology Next Generation Sequencing Market Share by Type (2016-2027)
Figure 21. North America Clinical Oncology Next Generation Sequencing Market Share by Application (2016-2027)
Figure 22. North America Clinical Oncology Next Generation Sequencing Market Share by Country (2016-2027)
Figure 23. United States Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Clinical Oncology Next Generation Sequencing Market Share by Type (2016-2027)
Figure 27. Europe Clinical Oncology Next Generation Sequencing Market Share by Application (2016-2027)
Figure 28. Europe Clinical Oncology Next Generation Sequencing Market Share by Country (2016-2027)
Figure 29. Germany Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Share by Region (2016-2027)
Figure 39. China Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Clinical Oncology Next Generation Sequencing Market Share by Type (2016-2027)
Figure 47. Latin America Clinical Oncology Next Generation Sequencing Market Share by Application (2016-2027)
Figure 48. Latin America Clinical Oncology Next Generation Sequencing Market Share by Country (2016-2027)
Figure 49. Mexico Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Clinical Oncology Next Generation Sequencing Market Share by Country (2016-2027)
Figure 55. Turkey Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Clinical Oncology Next Generation Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Illumina, Inc. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 60. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 61. Agilent Technologies Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 62. Myriad Genetics Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 63. Beijing Genomics Institute (BGI) Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 64. Perkin Elmer Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 65. Foundation Medicine Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 66. Pacific Bioscience Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 67. Oxford Nanopore Technologies Ltd. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 68. Paradigm Diagnostics Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 69. Caris Life Sciences Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 70. Partek, Inc. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 71. Eurofins Scientific S.E. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 72. Qiagen N.V. Revenue Growth Rate in Clinical Oncology Next Generation Sequencing Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の全ゲノム＆エクソームシーケンス市場規模・現状・予測（2021年-2027年） Whole Genome Sequencing sequences the complete DNA of an organism. In the case of a human this corresponds to about three billion base pairs of DNA. Whole genome sequencing entails sequencing all coding (exons) and noncoding (intron) nuclear DNA as well as mitochondrial DNA. This allows researchers …- 世界の第三世代シーケンシング技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Third-generation Sequencing Technology Market The global Third-generation Sequencing Technology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
- 世界の次世代シーケンシング（NGS）サンプル調製市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Next Generation Sequencing (NGS) Sample Preparation Market The global Next Generation Sequencing (NGS) Sample Preparation market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-stand…
- 世界の次世代配列決定サンプル調製市場規模・現状・予測（2021年-2027年） Next-generation sequencing (NGS) has enabled us to extract genetic information from samples faster, more reliably, and at lower cost than ever before. Getting your DNA ready for sequencing requires the preparation of a sequencing library as well as a few other steps that depend on the type of sample…
- 世界の全ゲノムシーケンシング（WGS）市場規模・現状・予測（2021年-2027年） Whole-genome sequencing (WGS) is the analysis of the entire genomic DNA sequence of a cell at a single time, providing the most comprehensive characterization of the genome. Market Analysis and Insights: Global Whole Genome Sequencing (WGS) Market The global Whole Genome Sequencing (WGS) market size…